Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic Colorectal Cancer

IMPORTANCE: Professional society guidelines recommend treating patients with metastatic colorectal cancer with targeted therapies, including epithelial growth factor receptor (EGFR) inhibitors and vascular endothelial growth factor (VEGF) inhibitors, depending on the presence or absence of certain m...

Descripción completa

Detalles Bibliográficos
Autores principales: Koroukian, Siran M., Booker, Benjamin D., Vu, Long, Schumacher, Fredrick R., Rose, Johnie, Cooper, Gregory S., Selfridge, J. Eva, Markt, Sarah C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857024/
https://www.ncbi.nlm.nih.gov/pubmed/36656585
http://dx.doi.org/10.1001/jamanetworkopen.2022.50030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857024/
https://www.ncbi.nlm.nih.gov/pubmed/36656585
http://dx.doi.org/10.1001/jamanetworkopen.2022.50030

Ejemplares similares